InChI=1S/C53H88O21/c1-23-32(57)36(61)39(64)43(68-23)74-42-38(63)34(59)25(20-55)70-46(42)71-26-21-66-45(41(35(26)60)73-44-40(65)37(62)33(58)24(19-54)69-44)72-31-11-12-49(6)27(48(31,4)5)9-13-50(7)28(49)10-14-53-29-17-47(2,3)15-16-52(29,22-67-53)30(56)18-51(50,53)8/h23-46,54-65H,9-22H2,1-8H3/t23-,24+,25+,26-,27-,28+,29+,30+,31-,32-,33+,34+,35-,36+,37-,38-,39+,40+,41+,42+,43-,44-,45-,46-,49-,50+,51-,52+,53-/m0/s1 |
MIBQGVWGYOOZBJ-ZDFBONGQSA-N |
[H][C@@]1(CO[C@@]([H])(O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])CC[C@]35OC[C@@]6(CCC(C)(C)C[C@@]36[H])[C@H](O)C[C@@]45C)C2(C)C)[C@H](O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@]1([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O |
|
Lysimachia clethroides
(NCBI:txid167892)
|
Found in
aerial part
(BTO:0001658).
Air-dried, powdered aerial parts were extracted with 70% aqueous ethyl alcohol.
See:
PubMed
|
Ardisia japonica
(NCBI:txid276775)
|
Found in
whole plant
(BTO:0001461).
See:
PubMed
|
Myrsine australis
(NCBI:txid450843)
|
Found in
leaf
(BTO:0000713).
See:
PubMed
|
Myrsine australis
(NCBI:txid450843)
|
Found in
twig
(BTO:0001411).
See:
PubMed
|
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
(via (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via saponin )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
(via (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside )
|
|
View more via ChEBI Ontology
Outgoing
|
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside
(CHEBI:66425)
has role
antineoplastic agent
(CHEBI:35610)
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside
(CHEBI:66425)
has role
plant metabolite
(CHEBI:76924)
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside
(CHEBI:66425)
is a
bridged compound
(CHEBI:35990)
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside
(CHEBI:66425)
is a
hexacyclic triterpenoid
(CHEBI:70994)
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside
(CHEBI:66425)
is a
tetrasaccharide derivative
(CHEBI:63567)
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside
(CHEBI:66425)
is a
triterpenoid saponin
(CHEBI:61778)
|
|
(3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl 6-deoxy-α-L-mannopyranosyl-(1→2)-β-D-glucopyranosyl-(1→4)-[β-D-glucopyranosyl-(1→2)]-α-L-arabinopyranoside
|
11058763
|
Reaxys Registry Number
|
Reaxys
|
17243725
|
PubMed citation
|
Europe PMC
|
21928797
|
PubMed citation
|
Europe PMC
|
7807121
|
PubMed citation
|
Europe PMC
|
|